MetLife, Inc. (NYSE:MET ) Q2 2024 Earnings Conference Call August 1, 2024 9:00 AM ET Company Participants John Hall - Global Head, IR Michel Khalaf - President and CEO John McCallion - CFO Ramy Tadros - Regional President, U.S. Business, Head, MetLife Holdings Lyndon Oliver - President, MetLife Asia Conference Call Participants Tom Gallagher - Evercore Suneet Kamath - Jefferies Ryan Krueger - KBW Wes Carmichael - Autonomous Research Jimmy Bhullar - JPMorgan Elyse Greenspan - Wells Fargo John Barnidge - Piper Sandler Mike Ward - Citi Operator Ladies and gentlemen, thank you for standing by. Welcome to the MetLife Second Quarter 2024 Earnings Conference Call.
The headline numbers for MetLife (MET) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
MetLife (MET) came out with quarterly earnings of $2.28 per share, beating the Zacks Consensus Estimate of $2.13 per share. This compares to earnings of $1.94 per share a year ago.
MetLife's (MET) Q2 results are likely to benefit from growing net investment income and a well-performing Latin America segment, partly offset by a fall in overall premiums.
Get a deeper insight into the potential performance of MetLife (MET) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife (MET) Arm, MIM, plans to utilize $250 million on new private equity opportunities.
MetLife's preferred shares, particularly the Series A with floating dividends, offer potential for investors in a 'higher for longer' inflation and interest rate environment. MetLife's strong financial performance in Q1 2021, with net profit covering preferred dividends by less than 8%. Series A preferred shares have a minimum 4% floor for dividends, with potential for higher yields based on 3 month SOFR rate adjustments.
MetLife (MET) and GeoBlue launch Globaline, a comprehensive expatriate benefits solution, offering unified medical and ancillary coverage, leveraging extensive global health networks for seamless support.
MetLife shares have outperformed peers, but life insurance stocks have not really been in favor given concerns about CRE losses and rate cuts. Higher rates have allowed MetLife to reprice its investment portfolio at higher rates and sell more spread products, and the benefits will last even as rates fall. There are understandable concerns about MetLife's CRE exposure (office in particular), as the insurer is overweight here, but losses will take years to materialize and can be absorbed.
MetLife (MET) expands collaboration with Micruity in a bid to develop MetLife's Universal Digital Platform and enhance access to retirement solutions.
MetLife's (MET) unit, Metropolitan Tower Life, is set to take over around $2.5 billion in defined benefit pension obligations from 3M, ensuring continued monthly payments to nearly 23,000 retirees.